New proposed settlement fund for victims in deadly 2012 meningitis outbreak up to $210 million


We also have more stories about:
(click the phrases to see a list)




BOSTON — A compensation fund for victims of a nationwide fungal meningitis outbreak blamed on a tainted steroid has grown to $210 million.

The 2012 outbreak killed 64 people and sickened more than 750 in 20 states. They were given an injected steroid produced by now-bankrupt New England Compounding Center of Framingham, Massachusetts.

Originally, more than $100 million was set aside for victims. The fund grew in December.

The Boston Globe ( ) reports that recent court documents show $70 million more in settlements from two companies that did business with the pharmacy.

The settlements must be agreed to by people seeking compensation and a bankruptcy judge. Lawyers told the Globe that payments from the fund could start later this year.

Two former New England Compounding executives pleaded not guilty to second-degree murder. Twelve others also face charges.

Information from: The Boston Globe,

All content copyright ©2015 Daily Journal, a division of Home News Enterprises unless otherwise noted.
All rights reserved. Click here to read our privacy policy.